What to know about J&J's vaccine — Inside Comcast Ventures — Gene therapy companies at the center of M&A interest

Subscribe to Insider View in browser


Yesterday was a big day in vaccine news. We learned more about how well Johnson & Johnson's vaccine works and how safe it is. And we also learned that Moderna has a plan for tackling variants. That includes a new shot it's sending to NIH for testing.  

Here's a look at how J&J's shot compares to Pfizer's and Moderna's>>

Also in healthcare news: What happened to Comcast Ventures, a onetime healthcare startup kingmaker, the companies gene therapy leaders may need to help fix safety issues, and Devoted Health quietly raised $380 million in 2020

comcast building

Comcast Ventures was once a kingmaker for healthcare benefits startups. Then its team fell apart.

Read the full story from Megan Hernbroth here>>


Gene therapy leaders may need M&A to solve their safety issues. Here are the 8 companies analysts are watching.

Read the full list from Allison DeAngelis here>>

Todd Park

Devoted Health quietly raised $380 million to gear up for fierce competition in the red-hot health-plan market for older people

Read the full scoop from Blake Dodge and Shelby Livingston here>>

More stories we're reading:

- Lydia


Was this email forwarded to you?
Download on the app store   Get it on google play
You received this email because you signed up to this
Insider newsletter using the
email: aymentanaze.news@blogger.com
Email preferences Unsubscribe
1 Liberty Plaza, 8th Floor. New York, NY 10006


Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

'Game of Thrones' gave fans of Missandei and Grey Worm something to love tonight